 |
|
 |
 |
 |
Proteases: Protease Inhibitors
 | | | Table 1: Selected Inhibitors | Inhibitors | Related Products
The proper functioning of the cell requires an optimum level of important structural proteins, enzymes, and regulatory proteins. One mechanism whereby cells achieve this steady state level is by proteolytic degradation. Protein degradation exhibits first order kinetics and is an energy-dependent, irreversible process brought about by the action of several peptidases. Peptidases (proteases) can be subdivided into two major groups: the endopeptidases and the exopeptidases, which cleave peptide bonds either at points within the protein or remove amino acids sequentially from either the N- or C-terminus, respectively. The term proteinase is also used as a synonym for endopeptidase. The International Union of Biochemistry and Molecular Biology (IUBMB) has recognized four classes of proteases: serine proteinases, cysteine proteinases, aspartic proteinases, and metalloproteinases.
In vivo, proteins are either protected in specialized compartments or they reside in a special protective conformation. Every protein isolated from cells is a potential substrate for proteolytic enzymes. Protease inhibitors are often used in experimental protocols that require extraction and analysis of intact proteins. These inhibitors block the activity of proteases and minimize tissue damage during purification procedures and organ perfusion studies. More recently, selected protease inhibitors have been used as anti-HIV agents.
Commonly used protease inhibitors are either synthetic or of bacterial or fungal origin. They inhibit protease activity in either a reversible or irreversible manner. Over 100 naturally occurring protease inhibitors have been identified so far. They behave as tight-binding reversible or pseudo-irreversible protease inhibitors preventing substrate access to the active site through steric hindrance. Some of them act by modifying an amino acid residue of the protease active site. For example, serine proteases are inactivated by phenylmethane sulfonyl fluoride (PMSF), which reacts with the active site serine, whereas the chloromethylketone derivatives react with the histidine of the catalytic triad. | | | | Table 1: Selected Protease Inhibitors | | Protease Inhibitor | Cat. No. | MW | Comments/Applications | Solubility | Suggested Working Concentration | | Acetyl-Pepstatin | | 643.8 | An aspartyl protease inhibitor that acts as an effective inhibitor of HIV-1 proteinase (Ki = 20 nM at pH 4.7). | 50% Acetic Acid | 100-200 nM | | AEBSF, Hydrochloride | | 239.5 | Water-soluble, non-toxic alternative to PMSF. Irreversible inhibitor of serine proteases. Reacts covalently with a component of the active site. Inhibits chymotrypsin, kallikrein, plasmin, trypsin, and related thrombolytic enzymes. | H2O | 0.1-1 mM | | ALLM | | 401.6 | Inhibitor of calpain I (Ki = 120 nM), calpain II (Ki = 230 nM), cathepsin B (Ki = 100 nM), and cathepsin L (Ki = 600 pM). | Methanol, Ethanol, DMSO | 0.2-2 mM | | ALLN | | 383.5 | Inhibitor of calpain I (Ki = 190 nM), calpain II (Ki = 220 nM), cathepsin B (Ki = 150 nM), and cathepsin L (Ki = 500 pM). See also Cat. No. 208750. | Methanol, Ethanol, DMSO | 0.2-2 mM |
| | | | | Inhibitors: Protease |
|
|
|
| Acetyl-Pepstatin |
110175 |
| AEBSF, Hydrochloride |
101500 |
| ALLM |
208721 |
| ALLN |
208719 |
| InSolution™ ALLN |
208750 |
| Amastatin, Streptomyces sp. |
129875 |
| e-Amino-n-caproic Acid |
1381 |
| Aminopeptidase N Inhibitor |
164602 |
| a1-Antichymotrypsin, Human Plasma |
178196 |
| Antipain, Dihydrochloride |
178223 |
| Antipain, Hydrochloride |
178220 |
| a2-Antiplasmin, Human Plasma |
178221 |
| Antithrombin III, Human Plasma |
169756 |
| a1-Antitrypsin, Human Plasma |
178251 |
| p-APMSF, Hydrochloride |
178281 |
| Aprotinin, Bovine Lung, Crystalline |
616370 |
| Aprotinin, Bovine Lung, Solution |
616399 |
| Aprotinin, Bovine, Recombinant, Nicotiana sp., Animal-Free |
616371 |
| ATBI, Synthetic |
189250 |
| Benzamidine, Hydrochloride |
199001 |
| Bestatin |
200484 |
| Bestatin Methyl Ester |
200485 |
| CA-074 |
205530 |
| CA-074 Me |
205531 |
| Calpastatin, Human, Recombinant, Domain I |
208900 |
| Calpeptin |
03-34-0051 |
| Carboxypeptidase Inhibitor, Potato |
217359 |
| Caspase Inhibitor, Negative Control |
342000 |
| Cathepsin B Inhibitor II |
219385 |
| Cathepsin G Inhibitor I |
219372 |
| Cathepsin Inhibitor II |
219417 |
| Cathepsin Inhibitor III |
219419 |
| Cathepsin Inhibitor I |
219415 |
| Cathepsin K Inhibitor I |
219377 |
| Cathepsin K Inhibitor II |
219379 |
| Cathepsin K Inhibitor III |
219381 |
| Cathepsin L Inhibitor I |
219421 |
| Cathepsin L Inhibitor II |
219426 |
| Cathepsin L Inhibitor IV |
219433 |
| Cathepsin L Inhibitor V |
219435 |
| Cathepsin L Inhibitor VI |
219495 |
| Cathepsin S Inhibitor |
219393 |
| Cathepsin/Subtilisin Inhibitor |
219420 |
| Chymostatin |
230790 |
| Chymotrypsin Inhibitor I, Potato |
230906 |
| Cystatin, Egg White |
240891 |
| 1,5-Dansyl-Glu-Gly-Arg Chloromethyl Ketone, Dihydrochloride |
251700 |
| 3,4-Dichloroisocoumarin |
287815 |
| Diisopropylfluorophosphate |
30967 |
| Dipeptidylpeptidase II Inhibitor |
317621 |
| Dipeptidylpeptidase IV Inhibitor I |
416200 |
| Dipeptidylpeptidase IV Inhibitor II |
317638 |
| E-64 Protease Inhibitor |
324890 |
| E-64, Immobilized |
324891 |
| Ecotin, E. coli |
330200 |
| EDTA, Disodium Salt, Dihydrate, Molecular Biology Grade |
324503 |
| EDTA, Tetrasodium Salt |
34103 |
| EGTA |
324625 |
| EGTA, Molecular Biology Grade |
324626 |
| Elastase Inhibitor I |
324692 |
| Elastase Inhibitor II |
324744 |
| Elastase Inhibitor III |
324745 |
| Elastatinal |
324691 |
| EST |
330005 |
| FUT-175 |
344960 |
| GGACK |
347436 |
| 2-Guanidinoethylmercaptosuccinic Acid |
369334 |
| HDSF |
373250 |
| HSV Replication Inhibitor, BP5 |
385883 |
| a-Iodoacetamide |
407710 |
| Kininogen, High Molecular Weight, Single Chain, Human Plasma |
422686 |
| Kininogen, High Molecular Weight, Two Chain, Human Plasma |
422688 |
| Kininogen, Low Molecular Weight, Human Plasma |
422685 |
| Leuhistin |
432077 |
| Leupeptin, Hemisulfate, Microbial |
108975 |
| a2-Macroglobulin, Human Plasma |
441251 |
| DL-2-Mercaptomethyl-3-guanidinoethylthiopropanoic Acid |
445825 |
| a1-PDX, Human, Recombinant, E. coli |
126850 |
| Pepstatin A, Synthetic |
516481 |
| Phenylmethylsulfonyl Fluoride |
52332 |
| Phosphoramidon, Disodium Salt |
525276 |
| PPACK II, Trifluoroacetate Salt |
520219 |
| PPACK, Dihydrochloride |
520222 |
| PPACK, Dihydrochloride, Biotinylated |
520224 |
| Prolyl Endopeptidase Inhibitor II |
537011 |
| Protease Arrest™ Reagent |
539124 |
| Protease Inhibitor Cocktail Set I |
539131 |
| Protease Inhibitor Cocktail Set II |
539132 |
| Protease Inhibitor Cocktail Set III, EDTA-Free |
539134 |
| Protease Inhibitor Cocktail Set IV |
539136 |
| Protease Inhibitor Cocktail Set V, EDTA-Free |
539137 |
| Protease Inhibitor Cocktail Set VI |
539133 |
| Protease Inhibitor Cocktail Set VII |
539138 |
| Protease Inhibitor Cocktail Set VIII |
539129 |
| Protease Inhibitor Set |
539128 |
| Serine Protease Inhibitor Cocktail Set I |
565000 |
| Na-Tosyl-Lys Chloromethyl Ketone, Hydrochloride |
616382 |
| Na-Tosyl-Phe Chloromethyl Ketone |
616387 |
| Tripeptidylpeptidase II Inhibitor |
645905 |
| Trypsin Inhibitor, Corn |
650345 |
| Trypsin Inhibitor, Soybean |
65035 |
| Trypsin Inhibitor, Soybean, High Activity |
650357 |
| D-Val-Phe-Lys Chloromethyl Ketone, Dihydrochloride |
627624 |
| (Z-LL)2 Ketone |
421050 |
|
| | | Other Related Products | | | | Protease Inhibitor Cocktail Set I, Cat. No. 539131 | A cocktail containing five protease inhibitors that will inhibit a broad range of proteases. Reconstitute each vial with 1 ml H2O to obtain a 100x stock solution. When diluted, 1x stock solution contains the following amount of inhibitors.
Product | Cat. No. | Mol. Wt. | 1x Concentration | Target Protease | | AEBSF, Hydrochloride | | 239.5 | 500 mM | Serine Proteases | | Aprotinin | | 6512 | 150 nM | Serine Proteases and Esterases | | E-64 Protease Inhibitor | | 357.4 | 1 mM | Cysteine Proteases | | EDTA, Disodium | | 372.2 | 500 mM | Metalloproteases | | Leupeptin, Hemisulfate | | 475.6 | 1 mM | Cysteine Proteases and Trypsin-like proteases |
|
| | | | | | | Protease Inhibitor Cocktail Set II, Cat. No. 539132 | This cocktail is recommended for use with bacterial cell extracts. Cocktail contains five protease inhibitors with broad specificity for the inhibition of aspartic, cysteine, serine, and metalloproteases as well as aminopeptidases. Reconstitute each vial with 1 ml DMSO and 4 ml H2O to obtain a 5 ml stock solution. When reconstitued each vial will contain the following amount of inhibitors. Note: 1 set = 1 vial of lyophilized protease inhibitor cocktail and 1 vial DMSO, 1 ml.
Product | Cat. No. | Mol. Wt. | Concentration in the Vial | Target Protease | | AEBSF, Hydrochloride | | 239.5 | 20 mM | Serine Proteases | | Bestatin | | 308.4 | 1.7 mM | Aminopeptidase B and Leucine Aminopeptidase | | E-64 Protease Inhibitor | | 357.4 | 200 mM | Cysteine Proteases | | EDTA, Disodium | | 372.2 | 500 mM | Metalloproteases | | Pepstatin A | | 685.9 | 2 mM | Aspartic Proteases |
|
| | | | | | | Protease Inhibitor Cocktail Set III, Cat. No. 539134 | This cocktail is recommended for use with mammalian cells and tissue extracts. Cocktail contains six protease inhibitors (in 1 ml of DMSO) with broad specificity for the inhibition of aspartic, cysteine, and serine proteases as well as aminopeptidases. Each vial contains the following amount of inhibitors. One ml is sufficient for 20 g of tissue.
Product | | | Concentration in the Vial | | | AEBSF, Hydrochloride | | 239.5 | 100 mM | Serine Proteases | | Aprotinin, Bovine Lung, Lyophilized | | 6512 | 80 mM | Broad Spectrum, Serine Proteases | | Bestatin | | 308.4 | 5 mM | Aminopeptidase B and Leucine Aminopeptidase | | E-64 Protease Inhibitor | | 357.4 | 1.5 mM | Cysteine Proteases | | Leupeptin, Hemisulfate | | 475.6 | 2 mM | Cysteine Proteases and Trypsin-like Proteases | | Pepstatin A | | 685.9 | 1 mM | Aspartic Proteases |
|
| | | | | | | | | Protease Inhibitor Cocktail Set IV, Cat. No. 539136 | This cocktail is recommended for fungal and yeast cell extracts. Cocktail contains four protease inhibitors (in 1 ml of DMSO) with broad specificity for the inhibition of aspartic-, cysteine-, metallo-, and serine-proteases. Each vial contains the following amount of inhibitors.
Product | | | Concentration in the Vial | | | AEBSF, Hydrochloride | | 239.5 | 100 mM | Serine Proteases | | E-64 Protease Inhibitor | | 357.4 | 1.5 mM | Cysteine Proteases | | Pepstatin A | | 685.9 | 2 mM | Aspartic Proteases | | o-Phenanthroline | | 198.2 | 500 mM | Metalloproteases |
|
| | | | | | | | | Protease Inhibitor Cocktail Set V, EDTA-Free, Cat. No. 539137 | A cocktail containing four protease inhibitors for the inhibition of serine, cysteine, but not metalloproteases. Reconstitute each vial with 1 ml H2O to obtain a 100x stock solution. When diluted to 1x stock solution, the set will contain the following amount of inhibitors.
Product | | | | | | AEBSF, Hydrochloride | | 239.5 | 500 mM | Serine Proteases | | Aprotinin, Bovine Lung, Crystalline | | 6512 | 150 nM | Broad Spectrum, Serine Proteases | | E-64 Protease Inhibitor | | 357.4 | 1 mM | Cysteine Proteases | | Leupeptin, Hemisulfate | | 475.6 | 1 mM | Cysteine Proteases and Trypsin-like Proteases |
|
| | | | | | | | | Protease Inhibitor Cocktail Set VI, Cat. No. 539133 | This cocktail is recommended for use with plant cell extracts. Cocktail contains six protease inhibitors (in 1 ml DMSO) with broad specificity for the inhibition of aspartic, cysteine, serine, and metalloproteases as well as aminopeptidases. Each vial contains the following amount of inhibitors. One ml is recommended for 30 g various plant tissues.
Product | | | Concentration in the Vial | | | AEBSF, Hydrochloride | | 239.5 | 200 mM | Serine Proteases | | Bestatin | | 308.4 | 10 mM | Aminopeptidase B and Leucine Aminopeptidase | | E-64 Protease Inhibitor | | 357.4 | 3 mM | Cysteine Proteases | | Leupeptin, Hemisulfate | | 475.6 | 2 mM | Cysteine Proteases and Trypsin-like Proteases | | o-Phenanthroline | | 198.2 | 500 mM | Metalloproteases | | Pepstatin A | | 685.9 | 2 mM | Aspartic Proteases |
|
| | | | | | | | | Protease Inhibitor Cocktail Set VII, Cat. No. 539138 | This cocktail is recommended for purification of proteins containing His•TagŪ sequences. Cocktail contains five protease inhibitors (in 1 ml DMSO) with broad specificity for the inhibition of cysteine, serine, aspartic, and thermolysin-like proteases and aminopeptidases. Each vial contains the following amount of inhibitors. One ml is recommended for the inhibition of proteases in 10 g cells.
Product | | | Concentration in the Vial | | | AEBSF, Hydrochloride | | 239.5 | 100 mM | Serine Proteases | | Bestatin | | 308.4 | 5 mM | Aminopeptidase B and Leucine Aminopeptidase | | E-64 Protease Inhibitor | | 357.4 | 1.5 mM | Cysteine Proteases | | Pepstatin A | | 685.9 | 2 mM | Aspartic Proteases | | Phosphoramidon | | 587.5 | 200 mM | Metalloendopeptidases |
|
| | | | | | | | | Protease Inhibitor Cocktail Set VIII, Cat. No. 539129 | A DMSO solution of three protease inhibitors with selective specificity for the inhibition of cysteine proteases, including calpains, cathepsins, and papain. Each vial contains the following amount of inhibitors. Product | | | Concentration in the Vial | | | ALLN | | 383.5 | 1.56 mM | Calpain I/II, Cathepsin B, Cathepsin L, Cysteine Proteases | | Cathepsin Inhibitor I | | 475.5 | 500 mM | Cathepsin B, Cathepsin L, Cathepsin S, Papain | | E-64 Protease Inhibitor | | 357.4 | 1.5 mM | Cysteine Proteases |
|
| | | | | | | Protease Arrest™ Reagent, Cat. No. 539124 | | An optimized concentration of various reversible and irreversible inhibitors to inhibit serine, cysteine, and calpain proteases. Suitable for the protection of proteins purified from animal tissues, plant tissues, yeast, and bacteria. Protease Arrest™ Reagent is provided as a 50x solution that when diluted in extraction buffer at pH 7.0 - 8.0 inhibits 95 - 98% of protease activity. EDTA is also provided separately to inhibit metalloproteinases. |
| | | | | | | Serine Protease Inhibitor Cocktail Set I, Cat. No. 565000 | A cocktail of four protease inhibitors that is useful for inhibition of a broad range of serine proteases. Reconstitute each vial with 1 ml of H2O to obtain a 100x stock solution. Each vial contains the following amount of inhibitors. Product | | | Concentration in the Vial | | | AEBSF, Hydrochloride | | 239.5 | 500 mM | Serine Proteases | | Aprotinin, Bovine Lung, Lyophilized | | 6512 | 420 nM | | | Elastatinal | | 512.6 | 20 mM | Serine Proteases | | GGACK, Dihydrochloride | | 392.8 | 1 mM | |
| | |
| | | |
 |
 |
|
|